Featured Study
Active Studies
-
Epstein-Barr Virus (EBV)
Support Groundbreaking Research by Participating in Our Mono Vaccine Study. Your involvement could help improve protection against infectious mononucleosis (mono) for young people everywhere. Criteria & Qualifications: • You are eligible if you meet the study's age requirements (10-30 years old). • Able to commit to the study duration, which involves attending study visits and participating in phone calls. • Able to attend required study visits and participate in required phone calls over the study period. Compensation: Contact us for more information.
Epstein-Barr Virus (EBV)
Read more -
Pneumococcal Vaccine Study
Support groundbreaking research by participating in our Pneumococcal Vaccine Study. Your involvement could help improve vaccine protection for children everywhere. Criteria & Qualifications: • Your child is eligible if they meet the study's age requirements. • Able to commit to 7–8 study visits over a period of 16–19 months. • Parent or guardian must be able to attend all 7–8 study visits over 16–19 months. Compensation: Contact us for more information.
Pneumococcal Vaccine Study
Read more -
Pediatric Respiratory Syncytial Virus (RSV)
We’re conducting a study to explore a new option for children with respiratory syncytial virus (RSV). This research aims to better understand how it can support recovery and overall health. Criteria & Qualifications: • Must be under 18 years old. • Diagnosed with RSV. • May have health factors like certain medical conditions. Compensation: Contact us for more information
Pediatric Respiratory Syncytial Virus (RSV)
Read more -
Respiratory Syncytial Virus (RSV)
We’re conducting a study to evaluate a new treatment for adults with acute respiratory syncytial virus (RSV) infection. The goal is to understand how this treatment may help reduce symptoms faster and improve health outcomes. Criteria & Qualifications: • Must be 18 years or older. • Diagnosed with acute RSV infection. • Exhibits risk factors such as age 60+, chronic lung diseases, or cardiovascular conditions. Compensation: Contact us for more information
Respiratory Syncytial Virus (RSV)
Read more -
Pediatric Obesity
This clinical trial is evaluating a new medication to improve health outcomes for adolescents living with obesity or overweight with weight-related health conditions. The goal is to assess how this treatment can reduce health risks and enhance quality of life. Criteria & Qualifications: • Must be an adolescent. • Living with obesity or overweight with related comorbidities. • Not currently taking medications for weight management. Compensation: Contact us for more information
Pediatric Obesity
Read more -
Obesity Trial
Join a clinical trial that aims to improve health outcomes for people living with obesity or being overweight. This study is testing a new medication to see how it can reduce health risks and improve the overall quality of life for individuals managing obesity. Criteria & Qualifications: • Must be 18 years or older. • Living with obesity or overweight. • Not currently taking medications for weight loss. Compensation: Contact us for more information
Obesity Trial
Read more -
NASH
Participating in this clinical trial can help improve treatments for a liver condition called MASH/NASH, which causes liver damage. The study is testing a new medicine to see if it can help improve liver health for people with moderate to advanced liver fibrosis. Criteria & Qualifications: • Must be 18 years or older. • Diagnosed with MASH/NASH and have moderate to advanced liver fibrosis. • Cannot join if you have other liver diseases or a history of chronic alcohol use. Compensation: Contact us for more information
NASH
Read more -
NASH/MASH
Help us improve treatment options for people with NASH and related health conditions. This clinical trial is studying a once-monthly therapy to reduce liver fat and improve metabolic health in diverse populations. Criteria & Qualifications: • Adults diagnosed with NASH. • Includes people with pre-diabetes or type 2 diabetes. • Open to individuals seeking better liver and metabolic health management. Compensation: Contact us for more information
NASH/MASH
Read more -
COVID-19 Treatment
Participate in a COVID-19 treatment study to help prevent severe illness. Join us in advancing research for high-risk individuals. Criteria & Qualifications: • Must be 18 years or older and diagnosed with COVID-19 within the last 4 days. • Experiencing at least 2 symptoms like cough, fatigue, fever, or shortness of breath in the last 4 days. • Have one or more high-risk factors such as advanced age (75+), immunosuppression, or certain chronic conditions like lung disease or obesity (BMI ≥ 35). Compensation: Contact us for more information.
COVID-19 Treatment
Read more
